title: Biochemical effects of oral sodium phosphate.
abstract: Our objective was to monitor serum and urine biochemical changes after oral sodium phosphate cleansing in a prospectively designed study. The study subjects were seven healthy, asymptomatic adults. Sodium phosphate 45 ml diluted in 45 ml water was given orally at baseline and 12 hr later. Calcium, ionized calcium, phosphorus, sodium, potassium, creatinine, and PTH were analyzed at 2, 4, 6, 9, 12, 14, 16, 18, 21 and 24 hr after the first challenge. Urinary calcium, phosphorus, sodium, potassium, and cyclic AMP were analyzed at baseline and every 2 hr after oral sodium phosphate. Blood pressure, pulse, and respiratory rate were recorded every 2 hr and symptom questionnaires using visual analog scales were completed. A marked rise in phosphorus (peak range 3.6-12.4 mg/dl, P < 0.001) and falls in calcium (P < 0.001) and ionized calcium (P < 0.001) were seen. Rises seen in PTH and urinary cAMP confirmed the physiologic significance of the biochemical effect. There were no significant changes in other serum and urine laboratory or clinical assessments. Reported significant symptoms included bloating, cramps, abdominal pain, and nausea. Significant hypocalcemia and hyperphosphatemia after oral sodium phosphate raises concern about its use in normal individuals. Oral sodium phosphate should not be administered in patients with cardiopulmonary, renal, or hepatic disease.
authors.affiliation: Department of Medicine, University of South Alabama, College of Medicine, Mobile, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: DiPalma
authors.forename: S E
authors.initials: SE
authors.lastname: Buckley
authors.forename: B A
authors.initials: BA
authors.lastname: Warner
authors.forename: R M
authors.initials: RM
authors.lastname: Culpepper
mesh_terms: D015746:Abdominal Pain / Q000139:chemically induced; D000284:Administration, Oral; D000328:Adult; D003113:Colonoscopy; D005260:Female; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced*; D008297:Male; D009325:Nausea / Q000139:chemically induced; D010710:Phosphates / Q000008:administration & dosage / Q000009:adverse effects*; D010758:Phosphorus / Q000097:blood*; D011446:Prospective Studies; D007507:Therapeutic Irrigation; D014883:Water-Electrolyte Imbalance / Q000139:chemically induced*
chemical_list: D010710:Phosphates; D010758:Phosphorus; C018279:sodium phosphate